SynthesisBMC pharmacology & toxicology2024

The effect of oral supplementation of Paricalcitol on C-reactive protein levels in chronic kidney disease patients: GRADE-assessed systematic review and dose-response meta-analysis of data from randomized controlled trials.

Seyyed Mostafa Arabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.